Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.
Inzelberg
Rivka
R
Hattori
Nobutaka
N
Mizuno
Yoshikuni
Y
D000328:Adult; D017668:Age of Onset; D001921:Brain / Q000378:metabolism / Q000503:physiopathology; D004298:Dopamine / Q000378:metabolism*; D005006:Ethnicity; D005260:Female; D006580:Genetic Carrier Screening; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006579:Heterozygote; D006801:Humans; D018476:Hypokinesia / Q000235:genetics / Q000503:physiopathology; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D010300:Parkinson Disease / Q000208:ethnology / Q000235:genetics* / Q000503:physiopathology*; D014202:Tremor / Q000235:genetics / Q000503:physiopathology; D044767:Ubiquitin-Protein Ligases / Q000235:genetics* / Q000378:metabolism
D007980:Levodopa; D044767:Ubiquitin-Protein Ligases; C111567:parkin protein; D004298:Dopamine